Correlation Between Virtus LifeSci and Goldman Sachs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virtus LifeSci and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virtus LifeSci and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virtus LifeSci Biotech and Goldman Sachs Hedge, you can compare the effects of market volatilities on Virtus LifeSci and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virtus LifeSci with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virtus LifeSci and Goldman Sachs.

Diversification Opportunities for Virtus LifeSci and Goldman Sachs

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Virtus and Goldman is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Virtus LifeSci Biotech and Goldman Sachs Hedge in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Hedge and Virtus LifeSci is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virtus LifeSci Biotech are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Hedge has no effect on the direction of Virtus LifeSci i.e., Virtus LifeSci and Goldman Sachs go up and down completely randomly.

Pair Corralation between Virtus LifeSci and Goldman Sachs

Considering the 90-day investment horizon Virtus LifeSci Biotech is expected to under-perform the Goldman Sachs. In addition to that, Virtus LifeSci is 1.82 times more volatile than Goldman Sachs Hedge. It trades about -0.39 of its total potential returns per unit of risk. Goldman Sachs Hedge is currently generating about 0.22 per unit of volatility. If you would invest  10,488  in Goldman Sachs Hedge on December 29, 2023 and sell it today you would earn a total of  373.00  from holding Goldman Sachs Hedge or generate 3.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Virtus LifeSci Biotech  vs.  Goldman Sachs Hedge

 Performance 
       Timeline  
Virtus LifeSci Biotech 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Virtus LifeSci Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Virtus LifeSci is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Goldman Sachs Hedge 

Risk-Adjusted Performance

20 of 100

 
Low
 
High
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Goldman Sachs Hedge are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak forward indicators, Goldman Sachs reported solid returns over the last few months and may actually be approaching a breakup point.

Virtus LifeSci and Goldman Sachs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virtus LifeSci and Goldman Sachs

The main advantage of trading using opposite Virtus LifeSci and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virtus LifeSci position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.
The idea behind Virtus LifeSci Biotech and Goldman Sachs Hedge pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios